Related references
Note: Only part of the references are listed.Estrogen receptor positive breast cancers have patient specific hormone sensitivities and rely on progesterone receptor
Valentina Scabia et al.
NATURE COMMUNICATIONS (2022)
A tumor-derived type III collagen-rich ECM niche regulates tumor cell dormancy
Julie S. Di Martino et al.
NATURE CANCER (2022)
Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Hyuna Sung et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
Intraductal xenografts show lobular carcinoma cells rely on their own extracellular matrix and LOXL1
George Sflomos et al.
EMBO MOLECULAR MEDICINE (2021)
The tumor cell-derived matrix of lobular breast cancer: a new vulnerability
Katelyn J. Kozma et al.
EMBO MOLECULAR MEDICINE (2021)
Decoupling epithelial-mesenchymal transitions from stromal profiles by integrative expression analysis
Michael Tyler et al.
NATURE COMMUNICATIONS (2021)
Single-cell lineage tracing of metastatic cancer reveals selection of hybrid EMT states
Kamen P. Simeonov et al.
CANCER CELL (2021)
Dynamic EMT: a multi-tool for tumor progression
Simone Brabletz et al.
EMBO JOURNAL (2021)
Crosstalk with lung epithelial cells regulates Sfrp2-mediated latency in breast cancer dissemination
Marco Montagner et al.
NATURE CELL BIOLOGY (2020)
The secreted protease Adamts18 links hormone action to activation of the mammary stem cell niche
Dalya Ataca et al.
NATURE COMMUNICATIONS (2020)
Guidelines and definitions for research on epithelial-mesenchymal transition
Jing Yang et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2020)
IL6/STAT3 Signaling Hijacks Estrogen Receptor α Enhancers to Drive Breast Cancer Metastasis
Rasmus Siersbaek et al.
CANCER CELL (2020)
Generalizing RNA velocity to transient cell states through dynamical modeling
Volker Bergen et al.
NATURE BIOTECHNOLOGY (2020)
Interleukin-6 trans-signaling is a candidate mechanism to drive progression of human DCCs during clinical latency
Melanie Werner-Klein et al.
NATURE COMMUNICATIONS (2020)
The current paradigm and challenges ahead for the dormancy of disseminated tumor cells
Emma Risson et al.
NATURE CANCER (2020)
Cancer progression and the invisible phase of metastatic colonization
Christoph A. Klein
NATURE REVIEWS CANCER (2020)
Intraclonal Plasticity in Mammary Tumors Revealed through Large-Scale Single-Cell Resolution 3D Imaging
Anne C. Rios et al.
CANCER CELL (2019)
Metastatic-niche labelling reveals parenchymal cells with stem features
Luigi Ombrato et al.
NATURE (2019)
E-cadherin is required for metastasis in multiple models of breast cancer
Veena Padmanaban et al.
NATURE (2019)
Intraductal patient-derived xenografts of estrogen receptor α-positive breast cancer recapitulate the histopathological spectrum and metastatic potential of human lesions
Maryse Fiche et al.
JOURNAL OF PATHOLOGY (2019)
Beyond 5 years: enduring risk of recurrence in oestrogen receptor-positive breast cancer
Juliet Richman et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2019)
Transmission of breast cancer by a single multiorgan donor to 4 transplant recipients
Yvette A. H. Matser et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2018)
EMT Subtype Influences Epithelial Plasticity and Mode of Cell Migration
Nicole M. Aiello et al.
DEVELOPMENTAL CELL (2018)
RNA velocity of single cells
Gioele La Manno et al.
NATURE (2018)
Identification of the tumour transition states occurring during EMT
Ievgenia Pastushenko et al.
NATURE (2018)
Oestrogen receptor α AF-1 and AF-2 domains have cell population-specific functions in the mammary epithelium
Stephanie Cagnet et al.
NATURE COMMUNICATIONS (2018)
Single cell RNA-seq highlights a role for a partial EMT in head and neck cancer
Sidharth V. Puram et al.
MOLECULAR & CELLULAR ONCOLOGY (2018)
Genomic modelling of the ESR1 Y537S mutation for evaluating function and new therapeutic approaches for metastatic breast cancer
A. Harrod et al.
ONCOGENE (2017)
The Rodent Liver Undergoes Weaning-Induced Involution and Supports Breast Cancer Metastasis
Erica T. Goddard et al.
CANCER DISCOVERY (2017)
20-Year Risks of Breast-Cancer Recurrence after Stopping Endocrine Therapy at 5 Years
Hongchao Pan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Humanized mouse model supports development, function, and tissue residency of human natural killer cells
Dietmar Herndler-Brandstetter et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Epithelial requirement for in vitro proliferation and xenograft growth and metastasis of MDA-MB-468 human breast cancer cells: oncogenic rather than tumor-suppressive role of E-cadherin
H. J. Hugo et al.
BREAST CANCER RESEARCH (2017)
A Preclinical Model for ERα-Positive Breast Cancer Points to the Epithelial Microenvironment as Determinant of Luminal Phenotype and Hormone Response
George Sflomos et al.
CANCER CELL (2016)
Fluorescent indicators for simultaneous reporting of all four cell cycle phases
Bryce T. Bajar et al.
NATURE METHODS (2016)
Epithelial-to-mesenchymal transition induces cell cycle arrest and parenchymal damage in renal fibrosis
Sara Lovisa et al.
NATURE MEDICINE (2015)
High Ki-67 score is indicative of a greater benefit from adjuvant chemotherapy when added to endocrine therapy in Luminal B HER2 negative and node-positive breast cancer
Carmen Criscitiello et al.
BREAST (2014)
Emergence of Constitutively Active Estrogen Receptor-α Mutations in Pretreated Advanced Estrogen Receptor-Positive Breast Cancer
Rinath Jeselsohn et al.
CLINICAL CANCER RESEARCH (2014)
Metastasis Dormancy in Estrogen Receptor-Positive Breast Cancer
Xiang H. -F. Zhang et al.
CLINICAL CANCER RESEARCH (2013)
TGF-β2 dictates disseminated tumour cell fate in target organs through TGF-β-RIII and p38α/β signalling
Paloma Bragado et al.
NATURE CELL BIOLOGY (2013)
Cell Adhesion and Shape Regulate TGF-Beta1-Induced Epithelial-Myofibroblast Transition via MRTF-A Signaling
Joseph W. O'Connor et al.
PLOS ONE (2013)
Framework models of tumor dormancy from patient-derived observations
Christoph A. Klein
CURRENT OPINION IN GENETICS & DEVELOPMENT (2011)
Disseminated tumor cells in the bone marrow of patients with ductal carcinoma in situ
Nicole Saenger et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
An intraductal human-in-mouse transplantation model mimics the subtypes of ductal carcinoma in situ
Fariba Behbod et al.
BREAST CANCER RESEARCH (2009)
Systemic spread is an early step in breast cancer
Yves Huesemann et al.
CANCER CELL (2008)
Loss of E-cadherin promotes metastasis via multiple downstream transcriptional pathways
Tamer T. Onder et al.
CANCER RESEARCH (2008)
Direct repression of cyclin d1 by SIP1 attenuates cell cycle progression in cells undergoing an epithelial mesenchymal transition
Jakob Mejlvang et al.
MOLECULAR BIOLOGY OF THE CELL (2007)
Dominant-negative E-cadherin inhibits the invasiveness of inflammatory breast cancer cells in vitro
Hui-Ming Dong et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2007)
Transforming growth factor-β1 induces epithelial-to-mesenchymal transition and apoptosis via a cell cycle-dependent mechanism
Y. Yang et al.
ONCOGENE (2006)
Snail blocks the cell cycle and confers resistance to cell death
S Vega et al.
GENES & DEVELOPMENT (2004)
Epithelial-mesenchymal transition and its implications for fibrosis
R Kalluri et al.
JOURNAL OF CLINICAL INVESTIGATION (2003)
E-cadherin expression in primary carcinomas of the breast and its distant metastases
PJ Kowalski et al.
BREAST CANCER RESEARCH (2003)
The two-handed E box binding zinc finger protein SIP1 downregulates E-cadherin and induces invasion
J Comijn et al.
MOLECULAR CELL (2001)
Persistent E-cadherin expression in inflammatory breast cancer
CG Kleer et al.
MODERN PATHOLOGY (2001)
The C3(1)/SV40 T-antigen transgenic mouse model of mammary cancer: ductal epithelial cell targeting with multistage progression to carcinoma
JE Green et al.
ONCOGENE (2000)
The transcription factor Snail is a repressor of E-cadherin gene expression in epithelial tumour cells
E Batlle et al.
NATURE CELL BIOLOGY (2000)
Share Paper
